Mixed Topics
News
FDA reiterates hydroxychloroquine limitations for COVID-19
An FDA Safety Communication restates that hydroxychloroquine and chloroquine are only for hospitalized COVID-19 patients who can’t enter a trial...
From the Journals
COVID-19: Experts call for ‘urgent’ global action to prevent suicide
An increase in suicide related to COVID-19 is not inevitable provided preventive action is prompt, the group notes.
From the Journals
Angiotensin drugs and COVID-19: More reassuring data
From the Journals
Hydroxychloroquine ineffective for COVID-19, VA study suggests
The retrospective study, which included
From the Journals
COVID-19: Experts hasten to head off mental health crisis
Across the two surveys, respondents’ primary concern was anxiety, which was cited in 750 responses.
From the Journals
Signature STEMI sign may be less diagnostic in the COVID-19 age
From the Journals
ACEI/ARBs linked with survival in hypertensive, Chinese COVID-19 patients
Photo Challenge
Dusky Pink Nodular Plaque on the Finger
A 38-year-old man presented with a persistent pruritic nodular plaque on the proximal right index finger of 4 months' duration. He reported...
For Residents
The DNA Mismatch Repair System in Sebaceous Tumors: An Update on the Genetics and Workup of Muir-Torre Syndrome
When patients present with a solitary sebaceous tumor, there is a high likelihood they have Muir-Torre syndrome and thus are at a high risk to...
Conference Coverage
D.C.-area blacks face increased risk of mortality from SJS/TEN
“It’s possible that the diagnoses are being delayed and so treatment is being delayed.”
From the Journals
JAK inhibitors may increase risk of herpes zoster
Patients who received Janus kinase (JAK) inhibitors had a 57% increased relative risk of herpes zoster infection.